Menu
Advanced
Structure search
List search
EN
CN
ES
FR
JP
KR
Wish Lists
Cart
Sign in
Sign in
Contact us
Catalog
of Screening Compounds
Screening Libraries
Building Blocks
Advanced
Structure search
List search
Homepage
>
Company
>
Media
>
Pharma News
>
2015
Pharma News, 2015
Lupin gets FDA nod for generic Femhrt tablets
Drug major Lupin has received US health regulator’s approval to market Fyavolv tablets, used to treat postmenopausal osteoporosis, in the American market.
Eagle Pharmaceuticals Announces FDA Approval of Docetaxel Injection, Non-Alcohol Formula
WOODCLIFF LAKE, N.
European Medicines Agency Accepts Fanaptum® (iloperidone) Marketing Authorization Application for the Treatment of Schizophrenia in Adults
Vanda Pharmaceuticals Inc.
Pollution may be a cause for antibiotic resistance
According to researchers, pollution may be a cause for antibiotic resistance and why the bacteria are becoming so resilient to medication.
Indian pharmaceutical industry likely to touch USD 55 bln by 2020: study
Indian pharmaceutical industry is expected to touch USD 55 billion by 2020 as against the current size of USD 18 billion but the exports may slow down to grow at a CAGR of 7.
Common anesthetic could be helpful in treating depression induced by diet
Researchers from Yale University have reported that , an anesthetic can reverse symptoms similar to depression in rats that were fed high-fat diet similar to the way it addresses synaptic damage from ...
New drug may slow down Alzheimer's: study
A drug that boosts activity in the brain's "garbage disposal" system may decrease levels of toxic proteins linked with Alzheimer's and other neurodegenerative diseases, scientists ha...
ZURAMPIC® (lesinurad) approved by US FDA for patients with gout
AstraZeneca today announced that the US Food and Drug Administration (FDA) has approved ZURAMPIC® (lesinurad) 200mg tablets in combination with a xanthine oxidase inhibitor (XOI...
Overseas M&A deals at 5-year high in pharma, healthcar
Overseas mergers and acquisitions (M&As) led deal activity in the pharmaceuticals and healthcare sector in 2015, their value hitting a five-year high.
Express Scripts releases better-than-expected 2016 forecast
ST.
Hillary Clinton Reveals Plan To Battle Alzheimer's Disease
NEW YORK (Reuters) - Democratic presidential candidate Hillary Clinton on Tuesday announced a slate of proposals to battle Alzheimer's disease and seek a cure by 2025, including an increas...
After Martin Shkreli exit, Turing plans job cuts and CEO search
Turing Pharmaceuticals said Tuesday that it will cut staff and start a search for a new chief executive after CEO Martin Shkreli resigned the position while facing federal charges of securities fraud ...
1
2
3
4
5
0
item
s
in Cart
Cart Subtotal:
Go to cart
You will be able to Pay Online or Request a Quote
Catalog
Services
Company
Catalog of Screening Compounds
Screening Libraries
Focused and Target Libraries
Active Reference Sets
Diversity Libraries
Preplated libraries
Inhibitors and Approved Drugs
Screening Compounds
Building blocks
Inhibitors and approved drugs
Drug Discovery Services
Custom chemistry. Chemistry FTE. Resynthesis.
Hit Follow up Support
Medicinal chemistry FTE
In silico drug design (CADD)
Discovery Biology. Biology FTE. In vitro studies.
Animal models
Toxicology and safety
ADME, DMPK. In vivo studies
Chemistry, manufacturing and controls
Company
News & Media
Contact us
Trends in discovery compounds